Do. Sobel et al., THE B-SUBUNIT OF CHOLERA-TOXIN INDUCES IMMUNOREGULATORY CELLS AND PREVENTS DIABETES IN THE NOD MOUSE, Diabetes, 47(2), 1998, pp. 186-191
The B-subunit of the cholera toxin molecule (CT-B) has T-cell immunomo
dulatory properties, Because the pathogenesis of diabetes in the nonob
ese diabetic (MOD) mouse model of IDDM is thought to be a T-cell-media
ted process due to an imbalance of immunoregulatory and anti-islet eff
ector cells, we examined the effect of CT-B administration on the deve
lopment of diabetes in the NOD mouse and assessed whether this potenti
al diabetes-sparing effect of CT-B is mediated by changes in immunoreg
ulatory and/or anti-islet cytotoxic effector cell activity. The admini
stration of either intravenous or intraperitoneal CT-B decreased the d
evelopment of diabetes with no apparent drug toxicity, At 6 months of
age, only 18% of CT-B vs. 75% of saline-treated animals had diabetes,
Histopathological examination revealed less islet atrophy in CT-B-trea
ted animals, The in vitro proliferative responses of mononuclear splen
ocytes and thymocytes to concanavalin A and lipolysaccharide and the p
roportion of B-cells and T-cell subsets were not altered by CT-B treat
ment, CT-B administration did not inhibit the primary immunization of
mice to tetanus toroid, The development of diabetes in irradiated MOD
mice was slower in the animals injected with spleen cells (SC) from CT
-B-treated than from saline-treated NOD mice, suggesting that CT-B dec
reases anti-islet effector cell activity. The injection of SC horn CT-
B-treated mice inhibited the adoptive transfer of diabetes by SC fi om
diabetic mice into irradiated NOD mice, documenting that, CT-B admini
stration induces regulatory cell activity, in conclusion, CT-B adminis
tration prevents the development of diabetes in NOD mice by inhibiting
the immune destruction of islets, This islet-sparing activity appears
mediated, at least in pare, by the induction of regulatory cells and,
in turn, suppression of anti-islet effector cells, which is not assoc
iated with generalised immunosuppression or T- or B-cell depletion.